ART2Dose:在线适应性放射治疗的综合剂量验证平台
Jingying Lin1, Mingli Chen1, Youfang Lai1
1Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Medical physics
|October 19, 2023
概括
一个新的软件,ART2Dose,简化了在线适应性放射治疗 (ART) 的质量保证. 它提供了高效和准确的剂量验证,减少了治疗检查时间,并改善了圆束CT和MRI导向ART的临床工作流程.
科学领域:
- 医学物理 医学物理
- 辐射瘤学 辐射瘤学
- 放射治疗技术 放射治疗技术
背景情况:
- 在线适应性放射治疗 (ART) 需要快速,准确的剂量验证.
- 目前商业软件的局限性阻碍了在时间敏感的在线ART工作流程中高效的二次剂量检查.
- 对体积剂量分配的独立验证对于适应性计划的准确性至关重要.
研究的目的:
- 推出ART2Dose,这是一个高效的在线质量保证 (QA) 平台,用于在线ART.
- 评估ART2Dose在Ethos和Unity治疗输送系统上的表现.
- 评估平台与临床质量保证工作流程的整合.
主要方法:
- 开发了ART2Dose,这是一个具有集成工作流程 (数据库,计算服务器,报告生成器,网页门户) 的二次剂量验证软件.
- 在40个适应性计划的临床前评估中,ART2剂量与Mobius3D进行了比较.
- 对1302个形光束CT导向自适应放射治疗 (CTgART) 和1278个MR图像导向自适应放射治疗 (MRgART) 分数进行了回顾性分析.
主要成果:
- ART2Dose显示了与Mobius3D.相比的或更高的马传导率.
- 治疗前检查时间减少了每计划3-4分钟.
- 追溯分析显示,CTgART的平均马通过率为99.61%,MRgART的平均通过率为97.75%.
- 平均计算时间为CTgART约1分钟,MRgART约2分钟.
结论:
- 通过简化实施,ART2Dose显著提高了在线ART工作流程.
- 该平台提供可靠和高效的在线质量保证,减少临床时间压力.
- ART2Dose将劳动密集型任务降至最低,提高了适应性放射治疗的整体效率.
更多相关视频
08:25Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
Published on: April 11, 2018
15.3K
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
2.8K
相关概念视频
Radiation: Applications
1.2K
The average temperature of Earth is the subject of much current discussion. Earth is in radiative contact with both the Sun and dark space; it receives almost all its energy from the radiation of the Sun and reflects some of it into outer space. Dark space is very cold, about 3 K, so Earth radiates energy into it. For instance, heat transfer occurs from soil and grasses, the rate of which can be so rapid that frost can occur on clear summer evenings, even in warm latitudes.
The average...
The average...
1.2K
Absorption of Radiation
741
The rate of heat transfer by emitted radiation is described by the Stefan-Boltzmann law of radiation:
741
Dose-Response Relationship: Overview
3.2K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.2K
